Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,785,000 | 1,784,000 | 1,937,000 | 1,139,000 | 3,559,000 |
| Marketable Securities | 6,302,000 | 11,128,000 | 9,682,000 | 17,694,000 | 13,680,000 |
| Receivables | 9,439,000 | 9,793,000 | 9,599,000 | 8,025,000 | 10,024,000 |
| Inventories | 8,222,000 | 8,233,000 | 8,029,000 | 7,508,000 | 8,184,000 |
| Income taxes - deferred | N/A | 3,723,000 | 3,598,000 | 3,374,000 | 3,686,000 |
| Other current assets | 6,711,000 | 12,412,000 | 12,445,000 | 12,186,000 | 2,450,000 |
| TOTAL | $33,459,000 | $47,073,000 | $45,290,000 | $49,926,000 | $41,583,000 |
| Non-Current Assets | |||||
| PPE Net | 13,701,000 | 13,521,000 | 13,467,000 | 13,385,000 | 14,036,000 |
| Investments And Advances | 18,722,000 | 2,905,000 | 2,859,000 | 2,767,000 | 6,444,000 |
| Intangibles | 97,660,000 | 86,376,000 | 87,526,000 | 88,622,000 | 100,920,000 |
| Other Non-Current Assets | 6,904,000 | 6,323,000 | 6,279,000 | 4,723,000 | 4,855,000 |
| TOTAL | $136,987,000 | $109,125,000 | $110,131,000 | $109,497,000 | $126,255,000 |
| Total Assets | $170,446,000 | $156,199,000 | $155,421,000 | $159,422,000 | $167,838,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,617,000 | 10,507,000 | 9,410,000 | 8,831,000 | 7,385,000 |
| Accounts payable and accrued liabilities | 3,942,000 | 4,002,000 | 4,156,000 | 4,674,000 | 4,297,000 |
| Accrued Expenses | 2,369,000 | 1,875,000 | 1,797,000 | 2,397,000 | 2,096,000 |
| Other current liabilities | 10,160,000 | 12,119,000 | 12,211,000 | 12,643,000 | 10,490,000 |
| TOTAL | $36,974,000 | $32,030,000 | $29,423,000 | $31,858,000 | $29,013,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,044,000 | 36,168,000 | 35,733,000 | 32,909,000 | 33,652,000 |
| aiOther Non-Current Liabilities | 25,305,000 | 24,886,000 | 27,509,000 | 27,185,000 | 27,989,000 |
| TOTAL | $68,077,000 | $64,244,000 | $66,839,000 | $63,806,000 | $67,161,000 |
| Total Liabilities | $105,051,000 | $96,274,000 | $96,263,000 | $95,664,000 | $96,174,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,534,122 | 5,531,048 | 5,559,929 | 5,551,805 | 5,780,474 |
| Common Shares | 468,000 | 468,000 | 468,000 | 467,000 | 466,000 |
| Retained earnings | 100,113,000 | 94,440,000 | 93,388,000 | 89,554,000 | 91,995,000 |
| Other shareholders' equity | -11,489,000 | -11,161,000 | -10,552,000 | -10,906,000 | -10,051,000 |
| TOTAL | $65,396,000 | $59,924,000 | $59,158,000 | $63,758,000 | $71,664,000 |
| Total Liabilities And Equity | $170,447,000 | $156,198,000 | $155,421,000 | $159,422,000 | $167,838,000 |